FACC home

clinical team

clinical trials

treatment options

about cancer

ways to give

saying goodbye

CSU pet hospice

emotional support

related links

join our mailing list
join our mailing list
events calendar

There are no events to display for this time period.

Follow us on Facebook Veterinary Teaching Hospital
CSU Campaign
Advancing Cancer Treatment
| Share

CSU Animal Cancer Center Clinical Trial

Patient Disease:
Cutaneous T-cell Lymphoma

Study Name:
Combined Lomustine and Asparaginase for Treatment of Canine Cutaneous T-cell Lymphoma: Frog-002

Purpose of the study:

  • To evaluate the efficacy of combining lomustine with asparaginase for dogs with cutaneous T-cell lymphoma

Primary Eligibility Criteria:

  • Diagnosis by biopsy of cutaneous T-cell lymphoma

Study Protocol:

  • Determine eligibility: Physical exam, lab work, documented diagnosis (biopsy)
  • Day 0: Physical exam, treat with chemotherapy and start prednisolone
  • Ongoing rechecks: Physical exam, lab work, chemotherapy, assessments of response through day 84
  • Then one-month rechecks following treatment

Owner Responsibilities:

  • To make and keep all appointments for the study protocol
  • Administration of oral medications at home
  • Commit to completing study protocol and follow up rechecks

Financial Incentives:

  • Asparaginase is provided at no cost

If you have further questions about any of our clinical trials, Please either login or sign up to submit a consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 5 business days